Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I
ConditionCannabis
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorYale University
About this trial
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Eligibility criteria
Qualifiers
At least one lifetime exposure to cannabis
Good physical and mental health
Disqualifiers
Cannabis naive individuals
Major current or recent stressors
Taking estrogen supplements or oral contraceptive pills (for women)
Sesame oil allergy
Trial design
Treatments tested in this trial
- Placebo
- Dronabinol
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov